Number of the records: 1  

Formation of gadolinium-ferritin from clinical magnetic resonance contrast agents

  1. SYS0537034
    LBL
      
    01000a^^22220027750^450
    005
      
    20240103225045.1
    014
      
    $a 85097958025 $2 SCOPUS
    014
      
    $a 000599127600006 $2 WOS
    017
      
    $a 10.1039/c9na00567f $2 DOI
    100
      
    $a 20210107d m y slo 03 ba
    101
      
    $a eng $d eng
    102
      
    $a GB
    200
    1-
    $a Formation of gadolinium-ferritin from clinical magnetic resonance contrast agents
    215
      
    $a 5 s.
    463
    -1
    $1 001 cav_un_epca*0508061 $1 011 $a 2516-0230 $e 2516-0230 $1 200 1 $a Nanoscale Advances $v Roč. 2, č. 12 (2020), s. 5567-5571 $1 210 $c Royal Society of Chemistry
    610
      
    $a nephrogenic systemic fibrosis
    610
      
    $a high signal intensity
    610
      
    $a dentate nucleus
    700
    -1
    $3 cav_un_auth*0346843 $a Neburková $b Jitka $p UOCHB-X $i Syntetická nanochemie $j Synthetic Nanochemistry $k 780/78 $l 780/78 $w Synthetic organic, materials and nano chemistry $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0296569 $a Rulseh $b A. M. $y CZ $4 070
    701
    -1
    $3 cav_un_auth*0401916 $a Chang $b S. L. Y. $y AU $4 070
    701
    -1
    $3 cav_un_auth*0314580 $a Raabová $b Helena $p UOCHB-X $i Syntetická nanochemie $j Synthetic Nanochemistry $k 780/78 $l 780/78 $w Synthetic organic, materials and nano chemistry $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0014289 $a Vejpravová $b J. $y CZ $4 070
    701
    -1
    $3 cav_un_auth*0215731 $a Dračínský $b Martin $p UOCHB-X $i NMR spektroskopie $j NMR Spectroscopy $k 910/91 $l 910/91 $w Spectral analytical methods and separations $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0267572 $a Tarábek $b Ján $p UOCHB-X $i NMR spektroskopie $j NMR Spectroscopy $k 910/91 $l 910/91 $w Spectral analytical methods and separations $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0053991 $a Kotek $b J. $y CZ $4 070
    701
    -1
    $3 cav_un_auth*0401917 $a Pingle $b M. $y CZ $4 070
    701
    -1
    $3 cav_un_auth*0103597 $a Majer $b Pavel $p UOCHB-X $i Drug discovery $j Drug discovery $k 390/39 $l 390/39 $w Bioorganic and medicinal chemistry $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0019595 $a Vymazal $b J. $y CZ $4 070 $z K
    701
    -1
    $3 cav_un_auth*0201976 $a Cígler $b Petr $p UOCHB-X $i Syntetická nanochemie $j Synthetic Nanochemistry $k 780/78 $l 780/78 $w Synthetic organic, materials and nano chemistry $y CZ $4 070 $z K $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    856
      
    $u https://doi.org/10.1039/C9NA00567F $9 RIV
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.